Diabetes-induced Alterations in HDL Subfractions Distribution.

Femlak, Marek; Gluba-Brzozka, Anna; Franczyk, Beata; Rysz, Jacek

Femlak, Marek; Gluba-Brzozka, Anna; Franczyk, Beata; Rysz, Jacek.

Afiliação

Femlak M; 105 Military Hospital with Outpatient Clinic in Zary, Domanskiego 2, 68-200 Zary, Poland.
Gluba-Brzozka A; Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital of Lodz, Zeromskiego 113, Lodz, 90-549, Poland.
Franczyk B; Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital of Lodz, Zeromskiego 113, Lodz, 90-549, Poland.
Rysz J; Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital of Lodz, Zeromskiego 113, Lodz, 90-549, Poland.

Curr Pharm Des ; 26(27): 3341-3348, 2020.

Article em En | MEDLINE | ID: mdl-30827232

Assuntos

Diabetes Mellitus Tipo 2; Inibidores de Hidroximetilglutaril-CoA Redutases; HDL-Colesterol; Diabetes Mellitus Tipo 2/tratamento farmacológico; Humanos

Palavras-chave

Diabetes mellitus; HDL subfraction; antiatherogenic properties; cardiovascular risk; dysfunctional HDL; statin treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google